Consistently, our results confirm the oncogenic role of SNHG17 in ovarian cancer, that is exosomal SNHG17 could promote ovarian cancer cell proliferation, migration, invasion and EMT in vitro and tumour growth and metastasis in vivo. This evidence concerns the gene SNHG17 and ovarian carcinoma.